Skip to main content

WELLS FARGO & COMPANY/MN

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in LXEO

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$143,459
-$558,949 QoQ
Shares Held
24,993
-64.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. LXEO ranks #201 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LXEO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $143,459 24,993
2025-12-31 $702,408 70,736
2025-09-30 $127,899 19,262
2025-06-30 $61,606 15,325
2025-03-31 $39,589 11,409
2024-12-31 $73,406 11,156
2024-09-30 $67,275 7,442
2024-06-30 $53,589 3,341
2024-03-31 $52,825 3,369
2023-12-31 $966 72